Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC.
about
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyThe Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte DifferentiationAn integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling.Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis.Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasisTargeted ovarian cancer treatment: the TRAILs of resistance.Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cellsPharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitorsOverexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.G protein coupled-receptor signaling and reversible lysine acetylation.
P2860
Q27015257-B42572C4-DB5B-4875-AF2B-8E3C6E720758Q30360840-678453CB-48F4-4CAF-B163-A715DA400A4EQ33882993-C3C84BAB-AA8F-474D-B606-527BAF1030EFQ33942430-AC73A7ED-4036-4858-A424-DAC8EB69F3F0Q34148745-AAFAE652-7D44-42AB-9B55-7B62E023A478Q34389111-CE446C31-21E8-4484-B06F-818539170002Q34419164-B485D137-8B09-457B-B819-6D33849587FFQ34980426-F1502F3C-1354-4C9C-B3C8-5C7B87C2B70FQ35609438-3327A343-F66F-4E72-A615-0FFC780629C9Q36569198-F7F2130B-9D70-4A89-B80B-827810CBE6E8Q37011621-6908A268-C2C1-48B2-88EB-93406B875781Q38398975-25B298E0-69CE-4067-AF26-22F8645B23C6Q38660494-886B5C2B-89A1-438A-9285-980634FD5BB3Q39519488-C16789ED-A063-43D6-BA9F-856635030E20Q39741685-18826AF0-5575-45D5-8E8E-EE6A06A76D7AQ40525719-20B596E2-7D56-4E08-A68A-9F7F761ADFD0Q47910938-798170D9-84C6-46C2-A611-744B39CA2E56
P2860
Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Lysophosphatidic acid protects ...... is through activation of HDAC.
@en
Lysophosphatidic acid protects cancer cells from histone deacetylase
@nl
type
label
Lysophosphatidic acid protects ...... is through activation of HDAC.
@en
Lysophosphatidic acid protects cancer cells from histone deacetylase
@nl
prefLabel
Lysophosphatidic acid protects ...... is through activation of HDAC.
@en
Lysophosphatidic acid protects cancer cells from histone deacetylase
@nl
P2093
P2860
P356
P1476
Lysophosphatidic acid protects ...... sis through activation of HDAC
@en
P2093
Bonnie A Graham
Ganchimeg Ishdorj
James B Johnston
Xianjun Fang
Xiaojie Hu
P2860
P304
16818-16829
P356
10.1074/JBC.M710177200
P407
P577
2008-04-11T00:00:00Z